Company
Thelper
- Biotech
- Location:
- Oslo (Oslo, Norway)
Description
Thelper develops first-in-class antiviral antibody drug conjugates (ADCs) targeting virally encoded biomarkers in aggressive solid tumors for therapeutic treatment of cancer patients and tumor microenvironments.
Related
Legend Biotech ($LEGN)Legend Biotech develops CAR-T cell therapies targeting blood cancers and solid tumors, advancing cellular research to expand treatment…
Cleara BiotechCleara Biotech develops peptide-based therapeutics and biomarkers to selectively eliminate p53-impaired cancer cells, producing D-amino…
TILT BiotherapeuticsTILT Biotherapeutics develops oncolytic viral immunotherapies that modify the tumor microenvironment to stimulate T‑cell responses and…
NETRIS PHARMANETRIS PHARMA develops therapeutics that target Netrin-1 to overcome resistance to chemotherapy, targeted therapy and immunotherapy,…
ONCOMATRYX BIOPHARMA SLOncomatryx develops biotechnology programs focused on modulating the tumor microenvironment.
Iovance Biotherapeutics ($IOVA)Iovance Biotherapeutics develops and manufactures tumor-infiltrating lymphocyte (TIL) cell therapies for treating solid tumors, running…
Gate2BrainGate2Brain develops peptide-based delivery technologies that transport therapeutics across biological barriers for applications including…
Vivere OncotherapiesVivere Oncotherapies develops bioengineered cancer immunotherapies designed to help patients’ immune systems target cold tumors and support…
Arsenal BioArsenal Bio develops in vivo T cell therapies and reprogrammed CAR T approaches for chronic diseases, including cancer and autoimmunity,…
AplagonAplagon develops first-in-class therapeutics for thromboinflammatory diseases, focusing on clinical-stage drug APAC to treat thrombotic and…
RS Research Inc.Develops polymer-drug conjugate delivery platforms for targeted chemotherapy and theranostics, used to improve therapeutic index for…
XENOTHERAXENOTHERA develops glyco-humanized antibody therapeutics and related immunological treatments for clinical use, pursuing products in…